Showing results (1161-1170 of 1,633) with videos related to
Sort By:
Pageof 164
The Journal of Antimicrobial Chemotherapy|March 25, 2014
Serratia marcescens harbouring SME-type class A carbapenemases in Canada and the presence of blaSME on a novel genomic island, SmarGI1-1L F Mataseje, D A Boyd, J Delport, et al.Oncotarget|April 19, 2017
Kinomic profiling identifies focal adhesion kinase 1 as a therapeutic target in advanced clear cell renal cell carcinomaArindam P Ghosh, Christopher D Willey, Joshua C Anderson, et al.Infection Control and Hospital Epidemiology|June 14, 2022
Effectiveness and acceptability of intranasal povidone-iodine decolonization among fracture fixation surgery patients to reduce Staphylococcus aureus nasal colonizationMarin L Schweizer, Loreen A Herwaldt, Linda Boyken, et al.Journal of Virology|April 17, 2015
Stable Phenotypic Changes of the Host T Cells Are Essential to the Long-Term Stability of Latent HIV-1 InfectionLillian Seu, Steffanie Sabbaj, Alexandra Duverger, et al.Contemporary Clinical Trials|April 22, 2021
Considerations for assessing physical function and physical activity in clinical trials during the COVID-19 pandemicSeol Ju E Moon, Annette DeVito Dabbs, Andrea L Hergenroeder, et al.Chemosphere|January 1, 2018
Variability of ethanol concentration in rainwater driven by origin versus season in coastal and inland North Carolina, USAKatherine M Mullaugh, Megumi S Shimizu, Joan D Willey, et al.Journal of Functional Biomaterials|July 14, 2018
A Decellularized Porcine Xenograft-Derived Bone Scaffold for Clinical Use as a Bone Graft Substitute: A Critical Evaluation of Processing and StructureDaniel N Bracey, Thorsten M Seyler, Alexander H Jinnah, et al.Neurology|March 25, 2016
Leisure-time physical activity associates with cognitive decline: The Northern Manhattan StudyJoshua Z Willey, Hannah Gardener, Michelle R Caunca, et al.Journal of Managed Care & Specialty Pharmacy|June 29, 2018
Real-World Characteristics and Treatment Patterns in Patients with Urticaria Initiating Omalizumab in the United StatesXuehua Ke, Abhishek Kavati, Debra Wertz, et al.Therapeutic Advances in Medical Oncology|August 8, 2018
Preclinical and phase I clinical studies of KW-2450, a dual IGF-1R/IR tyrosine kinase inhibitor, in combination with lapatinib and letrozoleHiroshi Umehara, Yoshimi Maekawa, Fumito Koizumi, et al.Pageof 164